Complete response of mantle cell lymphoma with central nervous system involvement at diagnosis with acalabrutinib - Case report.

Central nervous system (CNS) involvement by mantle cell lymphoma (MCL) is rare and portends a poor prognosis. We describe the first patient to have a complete response with front-line treatment with single-agent acalabrutinib for MCL CNS.